IBDEI0MQ ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22919,0)
 ;;=Z01.89^^89^1055^6
 ;;^UTILITY(U,$J,358.3,22919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22919,1,3,0)
 ;;=3^Diabetic Foot Exam
 ;;^UTILITY(U,$J,358.3,22919,1,4,0)
 ;;=4^Z01.89
 ;;^UTILITY(U,$J,358.3,22919,2)
 ;;=^5062632
 ;;^UTILITY(U,$J,358.3,22920,0)
 ;;=Z11.59^^89^1055^17
 ;;^UTILITY(U,$J,358.3,22920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22920,1,3,0)
 ;;=3^Viral Diseases Screen
 ;;^UTILITY(U,$J,358.3,22920,1,4,0)
 ;;=4^Z11.59
 ;;^UTILITY(U,$J,358.3,22920,2)
 ;;=^5062675
 ;;^UTILITY(U,$J,358.3,22921,0)
 ;;=Z13.6^^89^1055^4
 ;;^UTILITY(U,$J,358.3,22921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22921,1,3,0)
 ;;=3^Cardiovascular Disorder Screen
 ;;^UTILITY(U,$J,358.3,22921,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,22921,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,22922,0)
 ;;=Z12.12^^89^1055^15
 ;;^UTILITY(U,$J,358.3,22922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22922,1,3,0)
 ;;=3^Rectum Malignant Neoplasm Screen
 ;;^UTILITY(U,$J,358.3,22922,1,4,0)
 ;;=4^Z12.12
 ;;^UTILITY(U,$J,358.3,22922,2)
 ;;=^5062682
 ;;^UTILITY(U,$J,358.3,22923,0)
 ;;=Z71.89^^89^1055^13
 ;;^UTILITY(U,$J,358.3,22923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22923,1,3,0)
 ;;=3^Other Specified Counseling
 ;;^UTILITY(U,$J,358.3,22923,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,22923,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,22924,0)
 ;;=Z12.5^^89^1055^14
 ;;^UTILITY(U,$J,358.3,22924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22924,1,3,0)
 ;;=3^Prostate Malignant Neoplasm Screen
 ;;^UTILITY(U,$J,358.3,22924,1,4,0)
 ;;=4^Z12.5
 ;;^UTILITY(U,$J,358.3,22924,2)
 ;;=^5062688
 ;;^UTILITY(U,$J,358.3,22925,0)
 ;;=Z00.00^^89^1055^10
 ;;^UTILITY(U,$J,358.3,22925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22925,1,3,0)
 ;;=3^General Adult Medical Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,22925,1,4,0)
 ;;=4^Z00.00
 ;;^UTILITY(U,$J,358.3,22925,2)
 ;;=^5062599
 ;;^UTILITY(U,$J,358.3,22926,0)
 ;;=Z02.79^^89^1055^12
 ;;^UTILITY(U,$J,358.3,22926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22926,1,3,0)
 ;;=3^Medical Certificate Encounter
 ;;^UTILITY(U,$J,358.3,22926,1,4,0)
 ;;=4^Z02.79
 ;;^UTILITY(U,$J,358.3,22926,2)
 ;;=^5062641
 ;;^UTILITY(U,$J,358.3,22927,0)
 ;;=Z71.3^^89^1055^7
 ;;^UTILITY(U,$J,358.3,22927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22927,1,3,0)
 ;;=3^Dietary Counseling
 ;;^UTILITY(U,$J,358.3,22927,1,4,0)
 ;;=4^Z71.3
 ;;^UTILITY(U,$J,358.3,22927,2)
 ;;=^5063245
 ;;^UTILITY(U,$J,358.3,22928,0)
 ;;=Z71.7^^89^1055^11
 ;;^UTILITY(U,$J,358.3,22928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22928,1,3,0)
 ;;=3^HIV Counseling
 ;;^UTILITY(U,$J,358.3,22928,1,4,0)
 ;;=4^Z71.7
 ;;^UTILITY(U,$J,358.3,22928,2)
 ;;=^5063251
 ;;^UTILITY(U,$J,358.3,22929,0)
 ;;=Z71.6^^89^1055^16
 ;;^UTILITY(U,$J,358.3,22929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22929,1,3,0)
 ;;=3^Tobacco Abuse Counseling
 ;;^UTILITY(U,$J,358.3,22929,1,4,0)
 ;;=4^Z71.6
 ;;^UTILITY(U,$J,358.3,22929,2)
 ;;=^5063250
 ;;^UTILITY(U,$J,358.3,22930,0)
 ;;=Z00.01^^89^1055^9
 ;;^UTILITY(U,$J,358.3,22930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22930,1,3,0)
 ;;=3^General Adult Medical Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,22930,1,4,0)
 ;;=4^Z00.01
 ;;^UTILITY(U,$J,358.3,22930,2)
 ;;=^5062600
 ;;^UTILITY(U,$J,358.3,22931,0)
 ;;=D86.0^^89^1056^45
 ;;^UTILITY(U,$J,358.3,22931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22931,1,3,0)
 ;;=3^Sarcoidosis of Lung
 ;;^UTILITY(U,$J,358.3,22931,1,4,0)
 ;;=4^D86.0
 ;;^UTILITY(U,$J,358.3,22931,2)
 ;;=^5002442
 ;;^UTILITY(U,$J,358.3,22932,0)
 ;;=D86.1^^89^1056^47
 ;;^UTILITY(U,$J,358.3,22932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22932,1,3,0)
 ;;=3^Sarcoidosis of Lymph nodes
 ;;^UTILITY(U,$J,358.3,22932,1,4,0)
 ;;=4^D86.1
 ;;^UTILITY(U,$J,358.3,22932,2)
 ;;=^5002443
 ;;^UTILITY(U,$J,358.3,22933,0)
 ;;=D86.2^^89^1056^46
 ;;^UTILITY(U,$J,358.3,22933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22933,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22933,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,22933,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,22934,0)
 ;;=D86.89^^89^1056^48
 ;;^UTILITY(U,$J,358.3,22934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22934,1,3,0)
 ;;=3^Sarcoidosis of Other Sites
 ;;^UTILITY(U,$J,358.3,22934,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,22934,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,22935,0)
 ;;=D86.9^^89^1056^51
 ;;^UTILITY(U,$J,358.3,22935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22935,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,22935,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,22935,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,22936,0)
 ;;=D86.86^^89^1056^39
 ;;^UTILITY(U,$J,358.3,22936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22936,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,22936,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,22936,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,22937,0)
 ;;=D86.87^^89^1056^43
 ;;^UTILITY(U,$J,358.3,22937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22937,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,22937,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,22937,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,22938,0)
 ;;=D86.3^^89^1056^49
 ;;^UTILITY(U,$J,358.3,22938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22938,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,22938,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,22938,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,22939,0)
 ;;=D86.81^^89^1056^41
 ;;^UTILITY(U,$J,358.3,22939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22939,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,22939,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,22939,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,22940,0)
 ;;=D86.82^^89^1056^50
 ;;^UTILITY(U,$J,358.3,22940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22940,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,22940,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,22940,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,22941,0)
 ;;=D86.84^^89^1056^44
 ;;^UTILITY(U,$J,358.3,22941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22941,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,22941,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,22941,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,22942,0)
 ;;=D86.85^^89^1056^42
 ;;^UTILITY(U,$J,358.3,22942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22942,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,22942,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,22942,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,22943,0)
 ;;=D86.83^^89^1056^40
 ;;^UTILITY(U,$J,358.3,22943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22943,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,22943,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,22943,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,22944,0)
 ;;=D84.1^^89^1056^16
 ;;^UTILITY(U,$J,358.3,22944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22944,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,22944,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,22944,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,22945,0)
 ;;=D81.810^^89^1056^5
 ;;^UTILITY(U,$J,358.3,22945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22945,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,22945,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,22945,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,22946,0)
 ;;=E88.01^^89^1056^2
 ;;^UTILITY(U,$J,358.3,22946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22946,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,22946,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,22946,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,22947,0)
 ;;=J09.X1^^89^1056^25
 ;;^UTILITY(U,$J,358.3,22947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22947,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
